Published online Dec 19, 2026. doi: 10.5498/wjp.123228
Revised: July 27, 2026
Accepted: August 10, 2026
Published online: December 19, 2026
Processing time: 142 Days and 3.9 Hours
Perinatal depression (PPD) is a leading cause of maternal disability worldwide and is frequently accompanied by anxiety and post-traumatic stress disorder (PTSD). These comorbid conditions are associated with poor maternal and infant outcomes; however, their clinical complexity and treatment responses remain in
To investigate the clinical symptom complexity and treatment challenges asso
A total of 1024 perinatal women who attended the Affiliated Women’s Hospital of Jiangnan University between July 2020 and August 2025 were selected. Screening was conducted using the 9-item Patient Health Questionnaire Depression (PHQ-9), 7-item Generalized Anxiety Disorder scale, Childhood Trauma Questionnaire-Short Form, PTSD checklist for DSM-5, and City Birth Trauma Scale. Following diagnostic interviews using the Structured Clinical Interview for DSM-5 Diso
Overall, 54.55% of the patients had comorbid anxiety or PTSD. Compared with the group with depression alone, the groups with depression comorbid with PTSD and depression comorbid with anxiety and PTSD had higher Childhood Trauma Questionnaire total scores (49.83 ± 13.64 and 52.16 ± 14.27 vs 38.24 ± 9.63; P < 0.05) and lower CEQ-2 total scores (2.13 ± 0.67 and 2.04 ± 0.71 vs 2.84 ± 0.62; P < 0.05). The group with depression comorbid with anxiety and PTSD had the highest PHQ-9 total score (21.36 ± 4.21) and higher scores for suicidal ideation than the other groups (P < 0.05). The overall treatment response rate was 56.82%, with the highest rate observed in the group with depression alone (71.43%) and the lowest rate observed in the group with depression comorbid with anxiety and PTSD (25.00%). Multivariate logistic regression analysis revealed that a history of childhood trauma [odds ratio (OR) = 3.50, 95% confidence interval (CI): 1.91-6.41], traumatic birth experiences (OR = 2.80, 95%CI: 1.60-4.89), low social support (OR = 2.31, 95%CI: 1.29-4.14), triple comorbidity (OR = 3.94, 95%CI: 1.80-8.62), and a baseline PHQ-9 score ≥ 15 (OR = 1.85, 95%CI: 1.05-3.25) were independent predictors of treatment failure (P < 0.05).
The clinical presentation of PPD comorbid with anxiety or PTSD is complex, and treatment remains challenging. Childhood trauma, traumatic birth experiences, low social support, triple comorbidity, and greater baseline depression severity significantly influence treatment outcomes; therefore, clinical practice should prioritize screening for comorbidities and early intervention for trauma.
Core Tip: Perinatal depression frequently co-occurs with anxiety or posttraumatic stress disorder, forming a high risk clinical profile marked by greater symptom severity and markedly lower treatment response rates-particularly in cases with triple comorbidity. Childhood trauma, traumatic birth experiences, low perceived social support, and severe baseline depression independently predict poor outcomes. Routine screening for these comorbidities, paired with traumainformed assessment of early life and obstetric experiences, is essential to guide personalized interventions and optimize maternal and infant prognosis.